BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21664691)

  • 41. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
    Akutsu M; Suzuki K; Tsunoda S; Kano Y
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
    Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA).
    Hioe CE; Tuen M; Vasiliver-Shamis G; Alvarez Y; Prins KC; Banerjee S; Nádas A; Cho MW; Dustin ML; Kachlany SC
    PLoS One; 2011; 6(8):e23202. PubMed ID: 21850260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.
    Gupta A; Espinosa V; Galusha LE; Rahimian V; Miro KL; Rivera-Medina A; Kasinathan C; Capitle E; Aguila HA; Kachlany SC
    J Leukoc Biol; 2015 Mar; 97(3):439-46. PubMed ID: 25341726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
    Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
    J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
    Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.
    Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
    Anticancer Res; 2013 Oct; 33(10):4439-43. PubMed ID: 24123013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
    Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
    PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
    Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
    Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents.
    Macy ME; DeRyckere D; Gore L
    Invest New Drugs; 2012 Apr; 30(2):468-79. PubMed ID: 21046425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
    Dragoun M; Günther T; Frias C; Berkessel A; Prokop A
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):685-695. PubMed ID: 29374786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Applications of
    Kachlany SC; Vega BA
    Pathogens; 2024 Apr; 13(5):. PubMed ID: 38787206
    [No Abstract]   [Full Text] [Related]  

  • 54. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.
    Dileepan T; Kachlany SC; Balashova NV; Patel J; Maheswaran SK
    Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells.
    Dietmann A; Millonig A; Combes V; Couraud PO; Kachlany SC; Grau GE
    Microb Pathog; 2013; 61-62():43-50. PubMed ID: 23665198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (-)-Epicatechin enhances etoposide-induced antileukaemic effect in rats with acute myeloid leukaemia.
    Papiez MA; Bukowska-Straková K; Krzysciak W; Baran J
    Anticancer Res; 2012 Jul; 32(7):2905-13. PubMed ID: 22753754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
    Kachlany SC; Fine DH; Figurski DH
    Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
    Kano Y; Akutsu M; Suzuki K; Yoshida M
    Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia.
    Sajwani FH; Collin P; Adrian TE
    Leuk Res; 2017 Dec; 63():98-108. PubMed ID: 29127862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.
    Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M
    Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.